Health
Experimental safety switch reduces severity of CAR-T immunotherapy-related side effects – News-Medical.Net
UNC Lineberger Comprehensive Cancer Center researchers have successfully used an experimental safety switch, incorporated as part of a chimeric antigen receptor…
UNC Lineberger Comprehensive Cancer Center researchers have successfully used an experimental safety switch, incorporated as part of a chimeric antigen receptor T-cell (CAR-T) therapy, a type of immunotherapy, to reduce the severity of treatment side effects that sometimes occur. This advance was seen in a patient enrolled in a clinical trial using CAR-T to treat refractory acute B-cell leukemia. It demonstrates a proof-of-principle for possible expanded use of CAR-T immunotherapy paired with the…
-
Noosa News16 hours agoMan charged over allegedly abandoning Arnie the German shepherd in car after claiming dog and vehicle were stolen
-
Noosa News17 hours agoMotorcyclist dies in crash with truck
-
Noosa News18 hours agoSomerville House investigating after teachers’ dossier on students leaked
-
General23 hours agoSmall-town cleaner finds himself in legal battle with EnduroShield over product packaging